Cargando…
In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2
The 2019 coronavirus infectious disease (COVID-19) is caused by infection with the new severe acute respiratory syndrome coronavirus (SARS-CoV-2). Currently, the treatment options for COVID-19 are limited. The purpose of the experiments presented here was to investigate the effectiveness of ketotife...
Autores principales: | Kiani, Pantea, Scholey, Andrew, Dahl, Thomas A., McMann, Lauren, Iversen, Jacqueline M., Verster, Joris C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065848/ https://www.ncbi.nlm.nih.gov/pubmed/33810356 http://dx.doi.org/10.3390/v13040558 |
Ejemplares similares
-
Efficacy of Naproxen/Fexofenadine (SJP-003) in the Prevention of Side Effects of Influenza Vaccination: Four Case Studies
por: Kiani, Pantea, et al.
Publicado: (2022) -
The Efficacy of the Combination of Naproxen and Fexofenadine (SJP-003) to Prevent or Reduce Side Effects of Receiving Multiple Travel Vaccines: A Case Report
por: Kiani, Pantea, et al.
Publicado: (2022) -
The efficacy of a combination of naproxen and fexofenadine (SJP − 002) to inhibit the symptoms that are associated with viral upper respiratory tract infection: Four case reports of individuals with common cold
por: Išerić, Emina, et al.
Publicado: (2023) -
The Effects of SJP-001 on Alcohol Hangover Severity: A Pilot Study
por: Verster, Joris C, et al.
Publicado: (2020) -
A Comparison of the Antinociceptive Properties of SJP-005 and Morphine in Rats
por: Verster, Joris C, et al.
Publicado: (2021)